Careers
News & Events
contact
Search
about axogen
about axogen
management team
board of directors
partners
international partners
ethics and conduct
patents
our products
Our products
Avance
®
Nerve Graft
Axoguard
®
Nerve Connector
Axoguard
®
Nerve Protector
Axoguard
®
Nerve Cap
Axotouch
®
Two-Point Discriminator
For patients
patient experiences
About the nervous system
Causes of Nerve Damage
Nerve Damage Treatment Options
Peripheral Nerve Injury Map
Nerve Term Glossary
healthcare professionals
healthcare professionals
Our clinical research
Surgical Technique Videos
Understanding the mechanics of nerve repair
Registration and Licenses
investors
News / Events
Financial Information
Stock Data
SEC Filings
Corporate Governance
Additional Information
13631 Progress Blvd, Suite 400
Alachua, FL 32615
© 2019 Axogen, Inc.
Investors
Overview
News / Events
Overview
Press Releases
Axogen In the News
IR Calendar
Clinical Conferences
Presentations
Email Alerts
Financial Info
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Current Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Contact the Board
Additional Info
Contacts
FAQ
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Overview
Press Releases
Axogen In the News
IR Calendar
Clinical Conferences
Presentations
Email Alerts
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Category
All Releases
Financial Releases
Avance Nerve Graft Clinical Results Published
Jan 16, 2012
AxoGen to Present at the Noble Financial Equity Conference
Jan 9, 2012
AxoGen to Present at the Fourth Annual Biotech Showcase TM Conference
Jan 5, 2012
AxoGen, Inc. Announces New Stock Trading Symbol “AXGN”
Oct 12, 2011
1...
17
18
19
20
21
22
23
24
25
26
